Selected research
Market Outlook & Growth Opportunities
Global GMP Grade Viral Service Market Outlook and Growth Opportunities 2026
Market perspective
The global GMP Grade Viral Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for GMP Grade Viral Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for GMP Grade Viral Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for GMP Grade Viral Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the GMP Grade Viral Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the GMP Grade Viral Service market include AGC Biologics, Andelyn Biosciences, Catalent, Charles River Laboratories, CoJourney Inc, Creative Biogene, Flash-biosolutions, Lonza and ProBio CDMO, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global GMP Grade Viral Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of GMP Grade Viral Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents GMP Grade Viral Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global GMP Grade Viral Service market.
GMP Grade Viral Service Segment by Company
AGC Biologics
Andelyn Biosciences
Catalent
Charles River Laboratories
CoJourney Inc
Creative Biogene
Flash-biosolutions
Lonza
ProBio CDMO
ProBioGen AG
Sartorius Stedim Biotech
Takara Bio
Thermo Fisher Scientific
uBriGene
VectorBuilder
WuXi Advanced Therapies
GMP Grade Viral Service Segment by Type
Viral Vector Process Development Service
Gmp Manufacturing and Release Service
Analytical Method Development and Quality Research Service
Others
GMP Grade Viral Service Segment by Application
Gene Therapy and Cell Therapy Industry
Tumor Immunotherapy Industry
Vaccine Industry
Diagnostics Industry
Others
GMP Grade Viral Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global GMP Grade Viral Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the GMP Grade Viral Service key companies, revenue, market share, and recent developments.
3. To split the GMP Grade Viral Service breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions GMP Grade Viral Service market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify GMP Grade Viral Service significant trends, drivers, influence factors in global and regions.
6. To analyze GMP Grade Viral Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GMP Grade Viral Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of GMP Grade Viral Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GMP Grade Viral Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global GMP Grade Viral Service industry.
Chapter 3: Detailed analysis of GMP Grade Viral Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of GMP Grade Viral Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of GMP Grade Viral Service in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Viral Vector Process Development Service
- Gmp Manufacturing and Release Service
- Analytical Method Development and Quality Research Service
- Others
Applications
- Gene Therapy and Cell Therapy Industry
- Tumor Immunotherapy Industry
- Vaccine Industry
- Diagnostics Industry
- Others
Companies covered
- AGC Biologics
- Andelyn Biosciences
- Catalent
- Charles River Laboratories
- CoJourney Inc
- Creative Biogene
- Flash-biosolutions
- Lonza
- ProBio CDMO
- ProBioGen AG
- Sartorius Stedim Biotech
- Takara Bio
- Thermo Fisher Scientific
- uBriGene
- VectorBuilder
- WuXi Advanced Therapies
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global GMP Grade Viral Service Market Size, 2021 VS 2025 VS 2032
- 1.3 Global GMP Grade Viral Service Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 GMP Grade Viral Service Market Dynamics
- 2.1 GMP Grade Viral Service Industry Trends
- 2.2 GMP Grade Viral Service Industry Drivers
- 2.3 GMP Grade Viral Service Industry Opportunities and Challenges
- 2.4 GMP Grade Viral Service Industry Restraints
3 GMP Grade Viral Service Market by Company
- 3.1 Global GMP Grade Viral Service Company Revenue Ranking in 2025
- 3.2 Global GMP Grade Viral Service Revenue by Company (2021-2026)
- 3.3 Global GMP Grade Viral Service Company Ranking (2024-2026)
- 3.4 Global GMP Grade Viral Service Company Manufacturing Base and Headquarters
- 3.5 Global GMP Grade Viral Service Company Product Type and Application
- 3.6 Global GMP Grade Viral Service Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global GMP Grade Viral Service Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 GMP Grade Viral Service Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 GMP Grade Viral Service Market by Type
- 4.1 GMP Grade Viral Service Type Introduction
- 4.1.1 Viral Vector Process Development Service
- 4.1.2 Gmp Manufacturing and Release Service
- 4.1.3 Analytical Method Development and Quality Research Service
- 4.1.4 Others
- 4.2 Global GMP Grade Viral Service Sales Value by Type
- 4.2.1 Global GMP Grade Viral Service Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global GMP Grade Viral Service Sales Value by Type (2021-2032)
- 4.2.3 Global GMP Grade Viral Service Sales Value Share by Type (2021-2032)
5 GMP Grade Viral Service Market by Application
- 5.1 GMP Grade Viral Service Application Introduction
- 5.1.1 Gene Therapy and Cell Therapy Industry
- 5.1.2 Tumor Immunotherapy Industry
- 5.1.3 Vaccine Industry
- 5.1.4 Diagnostics Industry
- 5.1.5 Others
- 5.2 Global GMP Grade Viral Service Sales Value by Application
- 5.2.1 Global GMP Grade Viral Service Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global GMP Grade Viral Service Sales Value by Application (2021-2032)
- 5.2.3 Global GMP Grade Viral Service Sales Value Share by Application (2021-2032)
6 GMP Grade Viral Service Regional Value Analysis
- 6.1 Global GMP Grade Viral Service Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global GMP Grade Viral Service Sales Value by Region (2021-2032)
- 6.2.1 Global GMP Grade Viral Service Sales Value by Region: 2021-2026
- 6.2.2 Global GMP Grade Viral Service Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America GMP Grade Viral Service Sales Value (2021-2032)
- 6.3.2 North America GMP Grade Viral Service Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe GMP Grade Viral Service Sales Value (2021-2032)
- 6.4.2 Europe GMP Grade Viral Service Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific GMP Grade Viral Service Sales Value (2021-2032)
- 6.5.2 Asia-Pacific GMP Grade Viral Service Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America GMP Grade Viral Service Sales Value (2021-2032)
- 6.6.2 South America GMP Grade Viral Service Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa GMP Grade Viral Service Sales Value (2021-2032)
- 6.7.2 Middle East & Africa GMP Grade Viral Service Sales Value Share by Country, 2025 VS 2032
7 GMP Grade Viral Service Country-level Value Analysis
- 7.1 Global GMP Grade Viral Service Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global GMP Grade Viral Service Sales Value by Country (2021-2032)
- 7.2.1 Global GMP Grade Viral Service Sales Value by Country (2021-2026)
- 7.2.2 Global GMP Grade Viral Service Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA GMP Grade Viral Service Sales Value Growth Rate (2021-2032)
- 7.3.2 USA GMP Grade Viral Service Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA GMP Grade Viral Service Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada GMP Grade Viral Service Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada GMP Grade Viral Service Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada GMP Grade Viral Service Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico GMP Grade Viral Service Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico GMP Grade Viral Service Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico GMP Grade Viral Service Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany GMP Grade Viral Service Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany GMP Grade Viral Service Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany GMP Grade Viral Service Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France GMP Grade Viral Service Sales Value Growth Rate (2021-2032)
- 7.7.2 France GMP Grade Viral Service Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France GMP Grade Viral Service Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. GMP Grade Viral Service Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. GMP Grade Viral Service Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. GMP Grade Viral Service Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy GMP Grade Viral Service Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy GMP Grade Viral Service Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy GMP Grade Viral Service Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain GMP Grade Viral Service Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain GMP Grade Viral Service Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain GMP Grade Viral Service Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia GMP Grade Viral Service Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia GMP Grade Viral Service Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia GMP Grade Viral Service Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands GMP Grade Viral Service Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands GMP Grade Viral Service Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands GMP Grade Viral Service Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries GMP Grade Viral Service Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries GMP Grade Viral Service Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries GMP Grade Viral Service Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China GMP Grade Viral Service Sales Value Growth Rate (2021-2032)
- 7.14.2 China GMP Grade Viral Service Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China GMP Grade Viral Service Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan GMP Grade Viral Service Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan GMP Grade Viral Service Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan GMP Grade Viral Service Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea GMP Grade Viral Service Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea GMP Grade Viral Service Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea GMP Grade Viral Service Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India GMP Grade Viral Service Sales Value Growth Rate (2021-2032)
- 7.17.2 India GMP Grade Viral Service Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India GMP Grade Viral Service Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia GMP Grade Viral Service Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia GMP Grade Viral Service Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia GMP Grade Viral Service Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia GMP Grade Viral Service Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia GMP Grade Viral Service Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia GMP Grade Viral Service Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil GMP Grade Viral Service Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil GMP Grade Viral Service Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil GMP Grade Viral Service Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina GMP Grade Viral Service Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina GMP Grade Viral Service Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina GMP Grade Viral Service Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile GMP Grade Viral Service Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile GMP Grade Viral Service Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile GMP Grade Viral Service Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia GMP Grade Viral Service Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia GMP Grade Viral Service Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia GMP Grade Viral Service Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru GMP Grade Viral Service Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru GMP Grade Viral Service Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru GMP Grade Viral Service Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia GMP Grade Viral Service Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia GMP Grade Viral Service Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia GMP Grade Viral Service Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel GMP Grade Viral Service Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel GMP Grade Viral Service Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel GMP Grade Viral Service Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE GMP Grade Viral Service Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE GMP Grade Viral Service Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE GMP Grade Viral Service Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey GMP Grade Viral Service Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey GMP Grade Viral Service Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey GMP Grade Viral Service Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran GMP Grade Viral Service Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran GMP Grade Viral Service Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran GMP Grade Viral Service Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt GMP Grade Viral Service Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt GMP Grade Viral Service Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt GMP Grade Viral Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 AGC Biologics
- 8.1.1 AGC Biologics Company Information
- 8.1.2 AGC Biologics Business Overview
- 8.1.3 AGC Biologics GMP Grade Viral Service Revenue and Gross Margin (2021-2026)
- 8.1.4 AGC Biologics GMP Grade Viral Service Product Portfolio
- 8.1.5 AGC Biologics Recent Developments
- 8.2 Andelyn Biosciences
- 8.2.1 Andelyn Biosciences Company Information
- 8.2.2 Andelyn Biosciences Business Overview
- 8.2.3 Andelyn Biosciences GMP Grade Viral Service Revenue and Gross Margin (2021-2026)
- 8.2.4 Andelyn Biosciences GMP Grade Viral Service Product Portfolio
- 8.2.5 Andelyn Biosciences Recent Developments
- 8.3 Catalent
- 8.3.1 Catalent Company Information
- 8.3.2 Catalent Business Overview
- 8.3.3 Catalent GMP Grade Viral Service Revenue and Gross Margin (2021-2026)
- 8.3.4 Catalent GMP Grade Viral Service Product Portfolio
- 8.3.5 Catalent Recent Developments
- 8.4 Charles River Laboratories
- 8.4.1 Charles River Laboratories Company Information
- 8.4.2 Charles River Laboratories Business Overview
- 8.4.3 Charles River Laboratories GMP Grade Viral Service Revenue and Gross Margin (2021-2026)
- 8.4.4 Charles River Laboratories GMP Grade Viral Service Product Portfolio
- 8.4.5 Charles River Laboratories Recent Developments
- 8.5 CoJourney Inc
- 8.5.1 CoJourney Inc Company Information
- 8.5.2 CoJourney Inc Business Overview
- 8.5.3 CoJourney Inc GMP Grade Viral Service Revenue and Gross Margin (2021-2026)
- 8.5.4 CoJourney Inc GMP Grade Viral Service Product Portfolio
- 8.5.5 CoJourney Inc Recent Developments
- 8.6 Creative Biogene
- 8.6.1 Creative Biogene Company Information
- 8.6.2 Creative Biogene Business Overview
- 8.6.3 Creative Biogene GMP Grade Viral Service Revenue and Gross Margin (2021-2026)
- 8.6.4 Creative Biogene GMP Grade Viral Service Product Portfolio
- 8.6.5 Creative Biogene Recent Developments
- 8.7 Flash-biosolutions
- 8.7.1 Flash-biosolutions Company Information
- 8.7.2 Flash-biosolutions Business Overview
- 8.7.3 Flash-biosolutions GMP Grade Viral Service Revenue and Gross Margin (2021-2026)
- 8.7.4 Flash-biosolutions GMP Grade Viral Service Product Portfolio
- 8.7.5 Flash-biosolutions Recent Developments
- 8.8 Lonza
- 8.8.1 Lonza Company Information
- 8.8.2 Lonza Business Overview
- 8.8.3 Lonza GMP Grade Viral Service Revenue and Gross Margin (2021-2026)
- 8.8.4 Lonza GMP Grade Viral Service Product Portfolio
- 8.8.5 Lonza Recent Developments
- 8.9 ProBio CDMO
- 8.9.1 ProBio CDMO Company Information
- 8.9.2 ProBio CDMO Business Overview
- 8.9.3 ProBio CDMO GMP Grade Viral Service Revenue and Gross Margin (2021-2026)
- 8.9.4 ProBio CDMO GMP Grade Viral Service Product Portfolio
- 8.9.5 ProBio CDMO Recent Developments
- 8.10 ProBioGen AG
- 8.10.1 ProBioGen AG Company Information
- 8.10.2 ProBioGen AG Business Overview
- 8.10.3 ProBioGen AG GMP Grade Viral Service Revenue and Gross Margin (2021-2026)
- 8.10.4 ProBioGen AG GMP Grade Viral Service Product Portfolio
- 8.10.5 ProBioGen AG Recent Developments
- 8.11 Sartorius Stedim Biotech
- 8.11.1 Sartorius Stedim Biotech Company Information
- 8.11.2 Sartorius Stedim Biotech Business Overview
- 8.11.3 Sartorius Stedim Biotech GMP Grade Viral Service Revenue and Gross Margin (2021-2026)
- 8.11.4 Sartorius Stedim Biotech GMP Grade Viral Service Product Portfolio
- 8.11.5 Sartorius Stedim Biotech Recent Developments
- 8.12 Takara Bio
- 8.12.1 Takara Bio Company Information
- 8.12.2 Takara Bio Business Overview
- 8.12.3 Takara Bio GMP Grade Viral Service Revenue and Gross Margin (2021-2026)
- 8.12.4 Takara Bio GMP Grade Viral Service Product Portfolio
- 8.12.5 Takara Bio Recent Developments
- 8.13 Thermo Fisher Scientific
- 8.13.1 Thermo Fisher Scientific Company Information
- 8.13.2 Thermo Fisher Scientific Business Overview
- 8.13.3 Thermo Fisher Scientific GMP Grade Viral Service Revenue and Gross Margin (2021-2026)
- 8.13.4 Thermo Fisher Scientific GMP Grade Viral Service Product Portfolio
- 8.13.5 Thermo Fisher Scientific Recent Developments
- 8.14 uBriGene
- 8.14.1 uBriGene Company Information
- 8.14.2 uBriGene Business Overview
- 8.14.3 uBriGene GMP Grade Viral Service Revenue and Gross Margin (2021-2026)
- 8.14.4 uBriGene GMP Grade Viral Service Product Portfolio
- 8.14.5 uBriGene Recent Developments
- 8.15 VectorBuilder
- 8.15.1 VectorBuilder Company Information
- 8.15.2 VectorBuilder Business Overview
- 8.15.3 VectorBuilder GMP Grade Viral Service Revenue and Gross Margin (2021-2026)
- 8.15.4 VectorBuilder GMP Grade Viral Service Product Portfolio
- 8.15.5 VectorBuilder Recent Developments
- 8.16 WuXi Advanced Therapies
- 8.16.1 WuXi Advanced Therapies Company Information
- 8.16.2 WuXi Advanced Therapies Business Overview
- 8.16.3 WuXi Advanced Therapies GMP Grade Viral Service Revenue and Gross Margin (2021-2026)
- 8.16.4 WuXi Advanced Therapies GMP Grade Viral Service Product Portfolio
- 8.16.5 WuXi Advanced Therapies Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst